These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 9374462)
1. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Cui J; Shin T; Kawano T; Sato H; Kondo E; Toura I; Kaneko Y; Koseki H; Kanno M; Taniguchi M Science; 1997 Nov; 278(5343):1623-6. PubMed ID: 9374462 [TBL] [Abstract][Full Text] [Related]
2. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Sato H; Kondo E; Harada M; Koseki H; Nakayama T; Tanaka Y; Taniguchi M Proc Natl Acad Sci U S A; 1998 May; 95(10):5690-3. PubMed ID: 9576945 [TBL] [Abstract][Full Text] [Related]
3. Differential tumor surveillance by natural killer (NK) and NKT cells. Smyth MJ; Thia KY; Street SE; Cretney E; Trapani JA; Taniguchi M; Kawano T; Pelikan SB; Crowe NY; Godfrey DI J Exp Med; 2000 Feb; 191(4):661-8. PubMed ID: 10684858 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells. Shin T; Nakayama T; Akutsu Y; Motohashi S; Shibata Y; Harada M; Kamada N; Shimizu C; Shimizu E; Saito T; Ochiai T; Taniguchi M Int J Cancer; 2001 Feb; 91(4):523-8. PubMed ID: 11251976 [TBL] [Abstract][Full Text] [Related]
5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. Harada M; Seino K; Wakao H; Sakata S; Ishizuka Y; Ito T; Kojo S; Nakayama T; Taniguchi M Int Immunol; 2004 Feb; 16(2):241-7. PubMed ID: 14734609 [TBL] [Abstract][Full Text] [Related]
7. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection. Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715 [TBL] [Abstract][Full Text] [Related]
8. An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice. Dieli F; Taniguchi M; Kronenberg M; Sidobre S; Ivanyi J; Fattorini L; Iona E; Orefici G; De Leo G; Russo D; Caccamo N; Sireci G; Di Sano C; Salerno A J Immunol; 2003 Aug; 171(4):1961-8. PubMed ID: 12902499 [TBL] [Abstract][Full Text] [Related]
9. CD1d-specific NK1.1+ T cells with a transgenic variant TCR. Sköld M; Faizunnessa NN; Wang CR; Cardell S J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049 [TBL] [Abstract][Full Text] [Related]
10. Generation of Novel Traj18-Deficient Mice Lacking Vα14 Natural Killer T Cells with an Undisturbed T Cell Receptor α-Chain Repertoire. Dashtsoodol N; Shigeura T; Ozawa R; Harada M; Kojo S; Watanabe T; Koseki H; Nakayama M; Ohara O; Taniguchi M PLoS One; 2016; 11(4):e0153347. PubMed ID: 27064277 [TBL] [Abstract][Full Text] [Related]
11. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Kawano T; Cui J; Koezuka Y; Toura I; Kaneko Y; Motoki K; Ueno H; Nakagawa R; Sato H; Kondo E; Koseki H; Taniguchi M Science; 1997 Nov; 278(5343):1626-9. PubMed ID: 9374463 [TBL] [Abstract][Full Text] [Related]
12. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen. Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017 [TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor. Sato H; Nakayama T; Tanaka Y; Yamashita M; Shibata Y; Kondo E; Saito Y; Taniguchi M Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7439-44. PubMed ID: 10377433 [TBL] [Abstract][Full Text] [Related]
14. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells. Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221 [TBL] [Abstract][Full Text] [Related]
15. The contribution of NKT cells, NK cells, and other gamma-chain-dependent non-T non-B cells to IL-12-mediated rejection of tumors. Park SH; Kyin T; Bendelac A; Carnaud C J Immunol; 2003 Feb; 170(3):1197-201. PubMed ID: 12538676 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617 [TBL] [Abstract][Full Text] [Related]
18. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
19. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Smyth MJ; Crowe NY; Godfrey DI Int Immunol; 2001 Apr; 13(4):459-63. PubMed ID: 11282985 [TBL] [Abstract][Full Text] [Related]
20. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]